Reference
Wouters S, et al. Priority to End of Life Treatments? Views of the Public in the Netherlands. Value in Health 20: 107-117, Jan 2017. Available from: URL: http://dx.doi.org/10.1016/j.jval.2016.09.544
Rights and permissions
About this article
Cite this article
Netherlands does not support costly life-extending drugs. PharmacoEcon Outcomes News 772, 27 (2017). https://doi.org/10.1007/s40274-017-3775-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3775-4